Saturday, November 6, 2021 from 8:00 AM to 11:30 AM CDT
Add to Calendar 


8-8:15 am: Welcome and Intro – President Angela Mayorga

8:15-9:45 am: Tyler Kjorvestad, MD

9:45-10 am: Break

10-11:30 am: Scott T. Aaronson, MD


This event will take place via Zoom webinar. 

A link with Zoom information will be sent out on November 5th. 


Course Objectives:

  1. Review the history of psychedelic compounds and the theories behind their use. 
  2. Compare and contrast the pharmacodynamic and pharmacokinetic properties of psychedelic substances.
  3. Analyze the current psychiatric literature utilizing psychedelic agents.
  4. What is a putative mechanism of action for psychedelic therapy?
  5. Why is psychotherapy essential as part of the treatment model for psychedelic therapy?
  6. What are potential symptom targets for psychedelic assisted therapy?
  7. What are the risks associated with exposing psychiatrically ill patients to psychedelics?
  8. What are potential future models of treatment for psychedelic assisted psychotherapy?


Melissa M. 
Kansas Psychiatric Society 

Psychedelic Psychiatry 

Join us on November 6th for a virtual CME opportunity hosted by The Kansas Psychiatric Society featuring Tyler Kjorvestad, MD & Scott T. Aaronson, MD.


3 hours of CME are offered with this event, in order to receive CME credit you must participate in the live attendance check that will take place during the event. Refunds will not be given for those who fail to complete the event attendance.

Register Now! Registration is free for students and residents. Please email proof of your status as a student or resident to KansasPS10@gmail.com and you will be granted access to the discount code for this event.

Cancellation Policy: A $5 Processing fee will be deducted for any cancelled registrations. Refunds will not be given after the event, or to those who fail to complete the attendance.

Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American Psychiatric Association (APA) and the Kansas Psychiatric Society. The APA is accredited by the ACCME to provide continuing medical education for physicians. 

Designation: The APA designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credits (TM). Physicians should claim only the credit commensurate with the extent of their participation in the activity.